vimarsana.com

Page 284 - மனிதன் சேவைகள் செயலாளர் அலெக்ஸ் அசார் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

US decides to approve Moderna s COVID-19 vaccine on emergency basis, says FT report

US decides to approve Moderna s COVID-19 vaccine on emergency basis, says FT report 18 Dec 2020 Gulf Today Report The US Food and Drug Administration (FDA) decided on Thursday night to approve Moderna Inc s coronavirus vaccine on an emergency basis, the Financial Times (FT) reported, citing people close to the process. The report comes after the FDA said it informed Moderna that it would rapidly work towards the finalisation and issuance of emergency use authorisation (EUA) for its COVID-19 vaccine candidate, according to commissioner Stephen Hahn. Medics transport a woman, 77, with COVID-19 symptoms to a hospital in Yonkers, New York. AFP On Thursday, a panel of outside advisers to the FDA overwhelmingly endorsed the emergency use of Moderna s coronavirus vaccine, virtually assuring a second option for protecting against COVID-19 for a pandemic ravaged nation.

Mike Pence gets covid-19 vaccine as US deaths top 3,000 for third straight day

Mike Pence gets covid-19 vaccine as US deaths top 3,000 for third straight day U.S. Vice President Mike Pence receives the COVID-19 vaccine at the White House in Washington, U.S., December 18, 2020. REUTERS/Cheriss May (REUTERS)Premium Jeff Mason , Reuters Mike Pence, his wife Karen Pence, and Surgeon General Jerome Adams each rolled up their sleeves and took injections from medical staff in white coats, becoming the highest-profile recipients to receive the vaccine publicly Share Via Read Full Story WASHINGTON : US Vice President Mike Pence received his COVID-19 vaccine live on television on Friday, seeking to shore up public support for vaccinations after U.S. deaths from the coronavirus topped 3,000 for a third straight day.

The Latest: 2nd reported severe reaction to COVID-19 vaccine

The Latest: 2nd reported severe reaction to COVID-19 vaccine December 18, 2020 Both cases were in Alaska. In the latest, a worker, identified only as a female clinician, began experiencing probable anaphylactic symptoms about 10 minutes after receiving the shot Thursday in Fairbanks. Symptoms included tongue swelling, hoarse voice and difficulty breathing. She received two doses of epinephrine at the emergency department at Fairbanks Memorial Hospital and was discharged about six hours later. “Allergic reactions, though uncommon, can occur with injections of medications and vaccines,” Chief Medical Officer Dr. Angelique Ramirez said in a statement. “This is why our staff is trained and prepared to respond to any symptoms of anaphylaxis. Our employee is doing well and was able to go home yesterday.”

Moderna vaccines ship if FDA gives OK, health secretary says

US clears Moderna vaccine for COVID-19, 2nd shot in arsenal By LAURAN NEERGAARD and MATTHEW PERRONE | December 18, 2020 at 4:53 AM HST - Updated January 12 at 8:20 AM WASHINGTON (AP) The U.S. added a second COVID-19 vaccine to its arsenal Friday, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day. Much-needed doses are set to arrive Monday after the Food and Drug Administration authorized an emergency rollout of the vaccine developed by Moderna Inc. and the National Institutes of Health. The move marks the world’s first authorization for Moderna’s shots. The vaccine is very similar to one from Pfizer Inc. and Germany’s BioNTech that’s now being dispensed to millions of health care workers and nursing home residents as the biggest vaccination drive in U.S. history starts to ramp up.

Moderna s coronavirus vaccine expected to get FDA approval Friday; shipments could start this weekend

Moderna s coronavirus vaccine expected to get FDA approval Friday; shipments could start this weekend
nola.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nola.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.